Autism Spectrum DisorderNCT04587557
Storytelling With or Without Social Contextual Information in Children With Autistic Spectrum Disorder and Typical Development
A study testing Storytelling with social contextual information, Storytelling without social contextual information and Children with ASD in people with Autism Spectrum Disorder and Healthy, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
Trial summary
This study was to examine the effects of storytelling with or without contextual information on children with autism spectrum disorder (ASD) and typical development (TD). Read more about this study
- Who is it for?
- Ages 6 to 12 yearsHealthy volunteers can take part
- Conditions the study is for
- Autism Spectrum Disorder, Healthy
- What is being tested?
- Storytelling with social contextual information, Storytelling without social contextual information and Children with ASD
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 siteHong Kong
- Study dates
- Jun 2016to Dec 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 12 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- 1) children aged between 6 and 12 years old;
- 2) had a previous diagnosis of ASD from medical professionals;
- 3) studied in mainstream primary school;
- 4) had a composite IQ score of 80 or above
- 1) children aged between 6 and 12 years old;
- 2) had no developmental disorder or intellectual disability;
- 3) attended primary school.
Who cannot join
- NA
Trial locations and contacts
1 site in 1 country.
Hong Kong1 site
The Hong Kong Polytechnic University, Department of Rehabilitation Sciences
Hong Kong
About this study
Official title: The Effects of Storytelling With or Without Social Contextual Information Regarding Eye Gaze and Visual Attention in Children With Autistic Spectrum Disorder and Typical Development: A Randomized, Controlled Eye-tracking Study
This study was to examine the effects of storytelling with or without contextual information on children with autism spectrum disorder (ASD) and typical development (TD).
Read the detailed description
This was a 2 x 2 x 2 randomized controlled trial with 52 children (26 with ASD and 26 with TD) recruited in the community and randomized into four groups: 1) ASD Group 1 - storytelling with contextual information; 2) ASD Group 2 - storytelling without contextual information; 3) TD Group 1 - storytelling with contextual information; 4) TD Group 2 - storytelling without contextual information. All stories were photo-based and static in nature. The only difference between Group 1 and Group 2 was that the stories included and did not include social contextual information, respectively. Training was delivered in small groups, with eight sessions across four weeks, two sessions per week, and 30 minutes per session. Participants' total fixation duration (TFD), total visit duration (TVD), and total fixation count (TFC) on human faces from 20 photos and a video were recorded using the Tobii eye tracker.
- Conditions
- Autism Spectrum Disorder, Healthy
- Being tested
- Storytelling with social contextual information, Storytelling without social contextual information, Children with ASD, Children with TD
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Storytelling with social contextual informationBehavioural
Four out of 100 stories from a storytelling app (SAHK, 2013) that incorporated social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Storytelling without social contextual informationBehavioural
Four out of 100 stories from a storytelling app (SAHK, 2013) without social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Children with ASDOther
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with ASD.
Children with TDOther
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with TD.
| Study group | Role | What they receive |
|---|---|---|
| ASD Group 1 - storytelling with social contextual information | Experimental | Storytelling with social contextual information for children with Autism Spectrum Disorder Receives: Behavioral: Storytelling with social contextual information; Other: Children with ASD |
| ASD Group 2 - storytelling without social contextual information | Active comparator | Storytelling without social contextual information for children with Autism Spectrum Disorder Receives: Behavioral: Storytelling without social contextual information; Other: Children with ASD |
| TD Group 1 - storytelling with social contextual information | Experimental | Storytelling with social contextual information for typically developed children Receives: Behavioral: Storytelling with social contextual information; Other: Children with TD |
| TD Group 2 - storytelling without social contextual information | Active comparator | Storytelling without social contextual information for typically developed children Receives: Behavioral: Storytelling without social contextual information; Other: Children with TD |
What is being measured
The primary outcome is the main question the study is designed to answer.
Eye gaze on the eye tracker
Total fixation duration (TFD)
Measured: Change from baseline to 4 weeks
Eye gaze on the eye tracker
Total visit duration (TVD)
Measured: Change from baseline to 4 weeks
Eye gaze on the eye tracker
Total fixation count (TFC)
Measured: Change from baseline to 4 weeks
Secondary outcomes (2)
Trail Making Test
Trail Making Test A (TMT-A)
Measured: Change from baseline to 4 weeks
Trail Making Test
Trail Making Test B (TMT-B)
Measured: Change from baseline to 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Oct 2020
- Study startJun 2016
- Primary completionDec 2018
- Study completionDec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Autism Spectrum DisorderStudies of the same condition, open and under way.
- More trials run by The Hong Kong Polytechnic UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- The Hong Kong Polytechnic University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kenneth N. K. Fong, The Hong Kong Polytechnic University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04587557
- Sponsor's protocol ID
- HSEARS20160427001
- Status last verified
- Oct 2020
- First submitted
- 6 Oct 2020
- Last updated
- 14 Oct 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Upon request
Publications
Tang WYF, Fong KNK, Chung RCK. The Effects of Storytelling With or Without Social Contextual Information Regarding Eye Gaze and Visual Attention in Children with Autistic Spectrum Disorder and Typical Development: A Randomized, Controlled Eye-Tracking Study. J Autism Dev Disord. 2022 Mar;52(3):1257-1267. doi: 10.1007/s10803-021-05012-w. Epub 2021 Apr 28.
PubMed 33909213
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Storytelling With or Without Social Contextual Information Regarding Eye Gaze and Visual Attention in Children With Autistic Spectrum Disorder and Typical Development: A Randomized, Controlled Eye-tracking Study
- ClinicalTrials.gov ID
- NCT04587557
- Acronym / sponsor ID
- HSEARS20160427001
- Conditions
- Autism Spectrum Disorder, Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 52 participants (actual)
- Lead sponsor
- The Hong Kong Polytechnic UniversityUniversity, hospital or other
- Study start
- Jun 2016 (actual)
- Primary completion
- Dec 2018 (actual)
- Study completion
- Dec 2018 (actual)
- First posted
- 14 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was to examine the effects of storytelling with or without contextual information on children with autism spectrum disorder (ASD) and typical development (TD).
Detailed description
This was a 2 x 2 x 2 randomized controlled trial with 52 children (26 with ASD and 26 with TD) recruited in the community and randomized into four groups: 1) ASD Group 1 - storytelling with contextual information; 2) ASD Group 2 - storytelling without contextual information; 3) TD Group 1 - storytelling with contextual information; 4) TD Group 2 - storytelling without contextual information. All stories were photo-based and static in nature. The only difference between Group 1 and Group 2 was that the stories included and did not include social contextual information, respectively. Training was delivered in small groups, with eight sessions across four weeks, two sessions per week, and 30 minutes per session. Participants' total fixation duration (TFD), total visit duration (TVD), and total fixation count (TFC) on human faces from 20 photos and a video were recorded using the Tobii eye tracker.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| ASD Group 1 - storytelling with social contextual information | Experimental | Behavioral: Storytelling with social contextual information, Other: Children with ASDStorytelling with social contextual information for children with Autism Spectrum Disorder |
| ASD Group 2 - storytelling without social contextual information | Active comparator | Behavioral: Storytelling without social contextual information, Other: Children with ASDStorytelling without social contextual information for children with Autism Spectrum Disorder |
| TD Group 1 - storytelling with social contextual information | Experimental | Behavioral: Storytelling with social contextual information, Other: Children with TDStorytelling with social contextual information for typically developed children |
| TD Group 2 - storytelling without social contextual information | Active comparator | Behavioral: Storytelling without social contextual information, Other: Children with TDStorytelling without social contextual information for typically developed children |
Who may qualify
- Ages
- 6 to 12 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- 1) children aged between 6 and 12 years old;
- 2) had a previous diagnosis of ASD from medical professionals;
- 3) studied in mainstream primary school;
- 4) had a composite IQ score of 80 or above
- 1) children aged between 6 and 12 years old;
Key exclusion criteria (1 listed)
- NA
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Storytelling with social contextual informationFour out of 100 stories from a storytelling app (SAHK, 2013) that incorporated social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session. | Behavioural | ASD Group 1 - storytelling with social contextual information, TD Group 1 - storytelling with social contextual information |
| Storytelling without social contextual informationFour out of 100 stories from a storytelling app (SAHK, 2013) without social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session. | Behavioural | ASD Group 2 - storytelling without social contextual information, TD Group 2 - storytelling without social contextual information |
| Children with ASDFour out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with ASD. | Other | ASD Group 1 - storytelling with social contextual information, ASD Group 2 - storytelling without social contextual information |
| Children with TDFour out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with TD. | Other | TD Group 1 - storytelling with social contextual information, TD Group 2 - storytelling without social contextual information |
Primary outcome
Eye gaze on the eye tracker
Time frame: Change from baseline to 4 weeks
Total fixation duration (TFD)
Eye gaze on the eye tracker
Time frame: Change from baseline to 4 weeks
Total visit duration (TVD)
Eye gaze on the eye tracker
Time frame: Change from baseline to 4 weeks
Total fixation count (TFC)
2 secondary outcomes
Trail Making Test
Time frame: Change from baseline to 4 weeks
Trail Making Test
Time frame: Change from baseline to 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2020.
- Derived from this study: PubMed 33909213Tang WYF, Fong KNK, Chung RCK. The Effects of Storytelling With or Without Social Contextual Information Regarding Eye Gaze and Visual Attention in Children with Autistic Spectrum Disorder and Typical Development: A Randomized, Controlled Eye-Tracking Study. J Autism Dev Disord. 2022 Mar;52(3):1257-1267. doi: 10.1007/s10803-021-05012-w. Epub 2021 Apr 28.
- Individual participant dataSharing planned: No. Upon request
Related trials for Autism Spectrum Disorder
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
Recruiting
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
Transcranial Direct Current Stimulation, Autistic Spectrum Disorder
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism
Autism Spectrum Disorder, Autism
RecruitingPhase 2
A Study of Esomeprazole in Children With Autism
Autism, Autism Spectrum Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Storytelling with social contextual information, Storytelling without social contextual information and Children with ASD in people with Autism Spectrum Disorder and Healthy, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Eye gaze on the eye tracker (time frame: Change from baseline to 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04587557, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2020; AzTrials last refreshed its copy on 7 Nov 2026.